Knightsbridge Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Knightsbridge Asset Management's IBB Position: Q3 2026 in Review
Knightsbridge Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q3 2026, selling an estimated $602 and leaving 6,747 shares worth $1.42M. The position accounts for 0.16% of the portfolio, ranked #74.
Knightsbridge Asset Management first reported a position in IBB in Q2 2020 and has held it in 26 quarters since. The position peaked at $2.28M in Q4 2022. 1,026 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Knightsbridge Asset Management held 6,747 shares of iShares Biotechnology ETF worth $1.42M as of Q3 2026.
- Knightsbridge Asset Management sold 3 iShares Biotechnology ETF shares in Q3 2026, an estimated $602.
- iShares Biotechnology ETF made up 0.16% of Knightsbridge Asset Management's portfolio in Q3 2026, its #74 holding.
- Knightsbridge Asset Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 26 quarters since.
- Knightsbridge Asset Management's iShares Biotechnology ETF position peaked at $2.28M in Q4 2022.
- 1,026 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Knightsbridge Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.